These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6237529)

  • 21. [The territorial and age-related characteristics of the distribution of patients with non-A, non-B viral hepatitis infected via the fecal-oral mechanism in foci of elevated viral hepatitis morbidity in the Uzbek SSR].
    Makarova GI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 May; (5):35-8. PubMed ID: 2551112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis.
    Victor JC; Monto AS; Surdina TY; Suleimenova SZ; Vaughan G; Nainan OV; Favorov MO; Margolis HS; Bell BP
    N Engl J Med; 2007 Oct; 357(17):1685-94. PubMed ID: 17947390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Notified viral hepatitis in Auckland.
    Johnstone T
    N Z Med J; 1980 Jan; 91(651):22-4. PubMed ID: 6928061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Problem of epidemiology and prevention of viral hepatitis in the Osh district].
    Akmatov ShA; Mineeva RM; Kurbangalieva FK; Nurutdinov AS
    Zdravookhr Kirg; 1975; (1):39-43. PubMed ID: 49139
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prophylactic efficacy of reaferon in viral hepatitis A and acute respiratory infections in children].
    Iuldashev AK; Slepushkin AN; Khodzhaeva MA; Schastnyĭ EI; Kamilov FKh
    Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):65-9. PubMed ID: 2970744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epidemiological patterns in the spread of hepatitis A and the means for improving the measures for controlling this infection].
    Aleĭnik MD
    Zh Mikrobiol Epidemiol Immunobiol; 1985 May; (5):58-63. PubMed ID: 2994328
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis A.
    CMAJ; 1997 Feb; 156(4):545-6. PubMed ID: 9054826
    [No Abstract]   [Full Text] [Related]  

  • 28. [Organization of antiepidemiologic action against viral hepatitis in Kirghizia].
    Mineeva RM; Matveeva GE; Akmatov ShA
    Sov Zdravookhr Kirg; 1972; 3():38-42. PubMed ID: 4125532
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hepatitis A in Oslo].
    Hasle G; Espinoza R
    Tidsskr Nor Laegeforen; 1995 Jan; 115(2):215-7. PubMed ID: 7855814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prophylaxis for contacts of an index case of hepatitis A: immunoglobulins or vaccination?].
    Gendrel D; Launay O; Moulin F; Larnaudie S; Hau I; Laurent C; Dubos F; Laurichesse H
    Presse Med; 2007; 36(7-8):1072-7. PubMed ID: 17603920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multiyear and seasonal hepatitis A morbidity in different population age groups in certain areas].
    Schastnyĭ EI; Slepushkin AN; Iagodovskiĭ VV; Sharipov MK; Zimina ED
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jun; (6):44-8. PubMed ID: 2972146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term protective effect of post-exposure Havrix administration during viral hepatitis Type A outbreaks.
    Kohl I; Nemecek V; Summerová M; Chlíbek R; Nad'ová K; Mináriková O
    Eur J Epidemiol; 2006; 21(12):893-9. PubMed ID: 17160428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vaccinal prophylaxis of hepatitis A in servicemen of the Far East military district].
    Ogarkov PI; Demidovihc VU; Shappo VV; Mel'nichenko PI
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (1):47-50. PubMed ID: 12630353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of multiple gamma globulin administration on the effectiveness of seroprophylaxis in hepatitis A].
    Gorbunov MA; Sumarokov AA; Iaroshevskaia IIu; Ikoev VN; Pavlova LI
    Zh Mikrobiol Epidemiol Immunobiol; 1982; (11):91-6. PubMed ID: 6186108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunoglobulin or vaccine as post-exposure prophylaxis against hepatitis A. The vaccine is sufficient for many according to the first controlled study].
    Weiland O
    Lakartidningen; 2008 May 7-13; 105(19):1371-2. PubMed ID: 18574973
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hepatitis A in Poland in 2001].
    Sitarska-Gołebiowska J; Bielak A
    Przegl Epidemiol; 2003; 57(1):129-34. PubMed ID: 12926319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of the development of humoral immunity to hepatitis A in children's day care centers].
    Prikazchikov SA; Karetnyĭ IuV; Vakar EI; Balaian MS; Zenkov VA
    Vopr Virusol; 1988; 33(2):169-73. PubMed ID: 2842960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1996 Dec; 45(RR-15):1-30. PubMed ID: 9005304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preventing the spread of viral hepatitis.
    Frymoyer CL
    Am Fam Physician; 1993 Dec; 48(8):1479-86. PubMed ID: 8249779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.